Latest Gilead Sciences Stories
The Only Healthcare Creative Awards Voted on by the Industry. NEW YORK, NY (PRWEB) January 12, 2015 PM360, a leading health-marketing industry trade
Agreements support both treatment therapies while helping members, health plans and employers manage costs ST. PAUL, Minn., Jan.
CORK, Ireland, December 29, 2014 /PRNewswire/ -- -- Two Companies to also Collaborate on the Further Development of Complera(R), Marketed
Global Cystic Fibrosis Market 2015-2019 is a new industry research report which profiles key players like Actavis, Novartis, Gilead Sciences, Vertex Pharmaceuticals and F Hoffmann-La Roche.
LONDON, December 17, 2014 /PRNewswire/ -- Report Details Hepatitis C treatments - your guide to medical needs, R&D trends and future drug revenues Discover
HAVERFORD, Pa., Dec.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.